These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Eye diseases: a new use for interleukin-18 in sight. Bray N Nat Rev Drug Discov; 2014 Jun; 13(6):418. PubMed ID: 24833293 [No Abstract] [Full Text] [Related]
5. Therapeutic approaches for vision loss due to choroidal neovascularizations in age related macular degeneration. Costagliola C Curr Drug Targets; 2011 Feb; 12(2):133-7. PubMed ID: 20887248 [No Abstract] [Full Text] [Related]
6. Towards a rational approach to combination therapy for neovascular age-related macular degeneration. Arroyo JG Br J Ophthalmol; 2007 Feb; 91(2):130-1. PubMed ID: 17244655 [TBL] [Abstract][Full Text] [Related]
7. A very effective treatment for neovascular macular degeneration. Stone EM N Engl J Med; 2006 Oct; 355(14):1493-5. PubMed ID: 17021326 [No Abstract] [Full Text] [Related]
8. [Results of photodynamic treatment of choroidal neovascular membrane in age-related macular degeneration]. Dubská Z; Kalvodová B Cas Lek Cesk; 2006; 145(10):800, 802-3. PubMed ID: 17121073 [No Abstract] [Full Text] [Related]
9. Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration. Falavarjani KG; Sadda SR Curr Pharm Des; 2017; 23(4):535-541. PubMed ID: 27981904 [TBL] [Abstract][Full Text] [Related]
11. [Introduction to the topic: Off-label use of bevacizumab in the treatment of neovascular age-related macular degeneration]. Bartz-Schmidt KU; Holz FG Ophthalmologe; 2006 Jun; 103(6):461-2. PubMed ID: 16763861 [No Abstract] [Full Text] [Related]
12. Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degeneration. Sawada T; Ohji M Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):825. PubMed ID: 25480718 [No Abstract] [Full Text] [Related]
14. Antiangiogenic therapy in neovascular age-related macular degeneration. Lin RC; Rosenfeld PJ Int Ophthalmol Clin; 2007; 47(1):117-37. PubMed ID: 17237677 [No Abstract] [Full Text] [Related]
15. Profile of conbercept in the treatment of neovascular age-related macular degeneration. Lu X; Sun X Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634 [TBL] [Abstract][Full Text] [Related]
16. Is IL-10 a good target to inhibit choroidal neovascularisation in age-related macular disease? Lightman S; Calder V PLoS Med; 2006 Aug; 3(8):e364. PubMed ID: 16903781 [TBL] [Abstract][Full Text] [Related]
17. [New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]. Pauleikhoff D; Kirchhof B; Bertram B; Holz FG; Bartz-Schmidt UB; Bornfeld N; Bresgen M; Heimann H; Helbig H; Hörauf H; Kampik A; Lemmen KD; Roider J Ophthalmologe; 2011 Jan; 108(1):85-90. PubMed ID: 21253745 [No Abstract] [Full Text] [Related]
18. Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab. Barbazetto I; Saroj N; Shapiro H; Wong P; Freund KB Retina; 2010 Oct; 30(9):1376-85. PubMed ID: 20683380 [TBL] [Abstract][Full Text] [Related]